FOXK2 and colorectal cancer: There is more FOXK2 expression in colorectal cancer tissues than in normal tissues, and in metastatic tissues than in primary tissues, and in primary tissues of metastatic patients than in non-metastatic patients, which is associated with poor prognosis.